Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
about
Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/FhitCollecting duct carcinoma of the kidney: an immunohistochemical study of 11 casesFragile histidine triad protein: structure, function, and its association with tumorogenesis.The pagetoid variant of urothelial carcinoma in situ of urinary bladder in a cow.Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.Oncosuppressor proteins of fragile sites are reduced in cervical cancer.Biomarkers for bladder cancer management: present and future.Common fragile site tumor suppressor genes and corresponding mouse models of cancer.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma.Targeted therapies in the management of metastatic bladder cancerAssociation of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells.The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer.FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer.Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.The ubiquitous 'cancer mutational signature' 5 occurs specifically in cancers with deleted FHIT alleles.
P2860
Q24595534-928966F3-4B52-47E6-8DF9-955ADAB4D0FFQ24793771-A82DA736-981C-4944-81F9-3C2338B91D2FQ30383886-126611BB-36BB-4830-AA9A-1AEFBE7F4353Q31994723-480E26CB-0C4F-45B0-B6D4-54E83EBD7ED6Q34019362-D3B59922-D683-491E-B323-DED5890D309DQ34208784-06273697-721A-4DE0-A9BF-36B137643846Q34330247-1F7E707B-6B49-4FC2-A1E8-06251E589E80Q34448168-610B84F7-EB63-4169-B255-A7EEC45CCBF5Q34557827-93A93566-71A6-4074-A84C-255ACB5391EFQ36341182-58DF253D-8E03-4559-80B9-48C783837633Q36637133-C1BC0612-30FE-496A-824C-54411CCD1CDCQ37290448-3F3FD1F5-9A0C-4B65-A9FC-A4A1E1C07389Q40141225-E36B3711-FF6A-472F-B8E4-2DF6CBD4A58FQ40503168-BCA1881E-67F1-4793-B8E2-18233B278F54Q42290198-285F0072-9ED9-4F0B-BF25-D76D8395A35CQ43938159-26C88A98-0B8A-4FBE-8C03-A452EAD77056Q44771907-9EB83198-9DD6-4B24-8B61-EC2B88CDFB84Q45240527-C8D2A81D-D1EE-4989-90F0-6D032408EF7AQ47153130-90368CF3-1FC1-4DCE-BA7D-EE74175099B9
P2860
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
@ast
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
@en
type
label
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
@ast
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
@en
prefLabel
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
@ast
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
@en
P2093
P2860
P1476
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
@en
P2093
A J Kovatich
A Vecchione
C M Calviello
L G Gomella
M Gardiman
P2860
P304
P356
10.1016/S0002-9440(10)64745-1
P407
P577
2000-02-01T00:00:00Z